Total synthesis and functional analysis of non-ribosomal peptides

Chemical Record

Volumn 11, Issue 5, 2011, Pages 284-294

  Inoue, Masayuki ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

biological activity; ion channels; natural products; structure activity relationships; total synthesis

Indexed keywords

ANTILLATOXIN; BIOLOGICAL PRODUCT; CYCLOPEPTIDE; LIPOPEPTIDE; POLYTHEONAMIDE B; PROTEIN; SODIUM CHANNEL; SODIUM CHANNEL BLOCKING AGENT;

ARTICLE; CHANNEL GATING; CHEMISTRY; DRUG EFFECT; METABOLISM; STRUCTURE ACTIVITY RELATION; SYNTHESIS;

BIOLOGICAL AGENTS; ION CHANNEL GATING; LIPOPEPTIDES; PEPTIDES, CYCLIC; PROTEINS; SODIUM CHANNEL BLOCKERS; SODIUM CHANNELS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 80053571473     PISSN: 15278999     EISSN: 15280691     Source Type: Journal    
DOI: 10.1002/tcr.201100014     Document Type: Article

References (66)

1. For reviews of non-ribosomal peptides, see: (a), E. A. Felnagle, E. E. Jackson, Y. A. Chan, A. M. Podevels, A. D. Berti, M. D. McMahon, M. G. Thomas, Mol. Pharmaceutics 2008, 5, 191
2. (b), S. A. Sieber, M. A. Marahiel, Chem. Rev. 2005, 105, 715
3. (c), R. Finking, M. A. Marahiel, Annu. Rev. Microbiol. 2004, 58, 453
4. (d), D. Schwarzer, R. Finking, M. A. Marahiel, Nat. Prod. Rep. 2003, 20, 275.
5. For reviews, see: (a), D. Purves, G. J. Augustine, D. Fitzpatrick, W. C. Hall, A. S. LaMantia, J. O. McNamara, L. E. White, Ed. Neuroscience, 4th ed.; Sinauer Associates Inc., Sunderland, MA, 2008; Chapter 4
6. (b), F. M. Ashcroft, Nature 2006, 440, 440
7. (c), K. J. Swartz, Nature Rev. Neurosci. 2004, 5, 905
8. (d), R. MacKinnon, Angew. Chem. Int. Ed. 2004, 43, 4265.
9. Total synthesis and biological evaluation of ciguatoxin, an activator of voltage-gated sodium channels, has been performed in the Hirama laboratory. For representative papers on the synthesis, see: (a), M. Inoue, K. Miyazaki, Y. Ishihara, A. Tatami, Y. Ohnuma, Y. Kawada, K. Komano, S. Yamashita, N. Lee, M. Hirama, J. Am. Chem. Soc. 2006, 128, 9352
10. (b), M. Inoue, K. Miyazaki, H. Uehara, M. Maruyama, M. Hirama, Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 12013
11. (c), M. Inoue, M. Hirama, Acc. Chem. Res. 2004, 37, 961
12. (d), M. Hirama, T. Oishi, H. Uehara, M. Inoue, M. Maruyama, H. Oguri, M. Satake, Science 2001, 294, 1904.
13. For representative papers on the biological activity, see: (e), K. Yamaoka, M. Inoue, K. Miyazaki, M. Hirama, C. Kondo, E. Kinoshita, H. Miyoshi, I. Seyama, J. Biol. Chem. 2009, 284, 7597
14. (f), M. Inoue, N. Lee, K. Miyazaki, T. Usuki, S. Matsuoka, M. Hirama, Angew. Chem. Int. Ed. 2008, 27, 8611
15. (g), K. Yamaoka, M. Inoue, H. Miyahara, K. Miyazaki, M. Hirama, Br. J. Pharmacol. 2004, 142, 879
16. (h), M. Inoue, M. Hirama, M. Satake, K. Sugiyama, T. Yasumoto, Toxicon 2003, 41, 469.
17. W. A. Catterall, Neuron 2000, 26, 13.
18. (a), J. J. Clare, S. N. Tate, M. Nobbs, M. A. Romanos, Drug Discov. Today 2000, 5, 506
19. (b), A. Al-Sabi, J. McArthur, V. Ostroumov, R. J. French, Mar. Drugs 2006, 4, 157.
20. J. Orjala, D. G. Nagle, V. Hsu, W. H. Gerwick, J. Am. Chem. Soc. 1995, 117, 8281.
21. The first proposed NMR-based structure (4S, 5R)-1 was revised to be (4R, 5R)-1 by Shioiri and co-workers through total syntheses of the isomers: (a), F. Yokokawa, H. Fujiwara, T. Shioiri, Tetrahedron Lett. 1999, 40, 1915
22. total synthesis of (4S, 5S)-, (4S, 5R)-, (4R, 5S)- and (4R, 5R)-1: (b), F. Yokokawa, H. Fujiwara, T. Shioiri, Tetrahedron 2000, 56, 1759
23. total synthesis of (4S, 5R)-1: (c), F. Yokokawa, T. Shioiri, J. Org. Chem. 1998, 63, 8638
24. (d), J. D. White, R. Hanselmann, D. J. Wardrop, J. Am. Chem. Soc. 1999, 121, 1106
25. total synthesis of (4S, 5S)- and (4R, 5R)-1: (e), K-C. Lee, T-P. Loh, Chem. Comm. 2006, 40, 4209.
26. (a), S.-Y. Wang, G. K. Wang, Cell. Signal. 2003, 15, 151
27. (b), W. A. Catterall, S. Cestele, V. Yarov-Yarovoy, F. H. Yu, K. Konoki, T. Scheuer, Toxicon 2007, 49, 124.
28. Gerwick and Murray reported the extensive biological studies of antillatoxin as well as the SAR studies of (4S, 5S)-, (4S, 5R)-, (4R, 5S)- and (4R, 5R)-1. (a), F. W. Berman, W. H. Gerwick, T. F. Murray, Toxicon 1999, 37, 1645
29. (b), W. I. Li, F. W. Berman, T. Okino, F. Yokokawa, T. Shioiri, W. H. Gerwick, T. F. Murray, Proc. Nat. Acad. Sci. U.S.A. 2001, 98, 7599
30. (c), W. I. Li, B. L. Marquez, T. Okino, F. Yokokawa, T. Shioiri, W. H. Gerwick, T. F. Murray, J. Nat. Prod. 2004, 67, 559
31. (d), Z. Cao, J. George, W. H. Gerwick, D. G. Baden, J. D. Rainier, T. F. Murray, J. Pharmacol. Exper. Ther. 2008, 326, 604.
32. K. Okura, S. Matsuoka, R. Goto, M. Inoue, Angew. Chem. Int. Ed. 2010, 49, 329.
33. R. Goto, K. Okura, H. Sakazaki, T. Sugawara, S. Matsuoka, M. Inoue, Tetrahedron. 2011, 67, 6659.
34. N. Miyaura, A. Suzuki, Chem. Rev. 1995, 95, 2457-2483.
35. H. Ishitani, Y. Yamashita, H. Shimizu, S. Kobayashi, J. Am. Chem. Soc. 2000, 122, 5403.
36. M. Hirama, H. Hioki, S. Itô, Tetrahedron Lett. 1988, 29, 3125-3128.
37. C. R. Johnson, M. P. Braun, J. Am. Chem. Soc. 1993, 115, 11014-11015.
38. T. Hamada, T. Sugawara, S. Matsunaga, N. Fusetani, Tetrahedron Lett. 1994, 35, 719.
39. T. Hamada, S. Matsunaga, G. Yano, N. Fusetani, J. Am. Chem. Soc. 2005, 127, 110.
40. T. Hamada, S. Matsunaga, M. Fujiwara, K. Fujita, H. Hirota, R. Schmucki, P. Güntert, N. Fusetani, J. Am. Chem. Soc. 2010, 132, 12941.
41. The channel formation through β-helical conformation is known for a head-to-head dimer of a non-ribosomal pentadecapeptide antibiotic gramicidin A. The tubular structure of polytheonamide B is three times as long as that of gramicidin A. For a review, see: Gramicidin and related ion channel-forming peptides; Wiley & Sons, Chichester, 1999.
42. S. Oiki, I. Muramatsu, S. Matsunaga, N. Fusetani, Folia Pharmacol. Jpn 1997, 110 (Suppl. 1), 195.
43. M. Iwamoto, H. Shimizu, I. Muramatsu, S. Oiki, FEBS Lett. 2010, 584, 3995.
44. For reviews of synthetic channels, see: (a), R. S. Hector, M. S. Gin, Supramol. Chem. 2005, 17, 129
45. (b), U. Koert, L. Al-Momani, J. R. Pfeifer, Synthesis 2004, 1129
46. (c), S. Matile, A. Som, N. Sordé, Tetrahedron 2004, 60, 6405
47. (d), D. T. Bong, T. D. Clark, J. R. Granja, M. R. Ghadiri, Angew. Chem. Int. Ed. 2001, 40, 988
48. (e), R. E. Koeppe II, O. S. Andersen, Annu. Rev. Biophys. Biomol. Struct. 1996, 25, 231.
49. (a), M. Inoue, N. Shinohara, S. Tanabe, T. Takahashi, K. Okura, H. Itoh, Y. Mizoguchi, M. Iida, N. Lee, S. Matsuoka, Nature Chem. 2010, 2, 280
50. for an account, see: (b), M. Inoue, S. Matsuoka, Isr. J. Chem. 2011, 51, 346.
51. S. Matsuoka, Y. Mizoguchi, H. Itoh, K. Okura, N. Shinohara, M. Inoue, Tetrahedron Lett. 2010, 51, 4644.
52. W. C. Chan, P. D. White, Fmoc Solid Phase Peptide Synthesis; Oxford Univ. Press, New York, 2000.
53. For reviews for peptide ligation methods, see: (a), Y. Yuan, J. Chen, Q. Wan, R. M. Wilson, S. J. Danishefsky, Peptide Sci. 2010, 94, 373
54. (b), P. E. Dawson, S. B. H. Kent, Annu. Rev. Biochem. 2000, 69, 923
55. (c), K. Kimmerlin, D. Seebach, J. Peptide. Res. 2005, 65, 229
56. (d), B. L. Nilsson, M. B. Soellner, R. T. Raines, Ann. Rev. Biophys. Biomol. Struct. 2005, 34, 91
57. (e), E. T. Kaiser, H. Mihara, G. A. Laforet, J. W. Kelly, L. Walters, M. A. Findeis, T. Sasaki, Science 1989, 243, 187.
58. K. Barlos, O. Chatzi, D. Gatos, G. Stavropoulos, Int. J. Peptide Protein Res. 1991, 37, 513.
59. S. Wang, J. Am. Chem. Soc. 1973, 95, 1328.
60. S. Aimoto, Biopolymers 1999, 51, 247.
61. S. Matsuoka, N. Shinohara, T. Takahashi, M. Iida, M. Inoue, Angew. Chem. Int. Ed. 2011, 50, 4879.
62. A. D. Bangham, M. W. Hill, N. G. A. Miller, in Methods in Membrane Biology, (Ed.:, E. D. Korn,), Plenum Press, New York, 1974, p. 1.
63. J. N. Weinstein, R. Blumenthal, R. D. Klausner, Methods in Enzymol. 1986, 128, 657-668.
64. D. F. Babcock, J. Biol. Chem. 1983, 258, 6380.
65. J. N. Weinstein, R. D. Klausner, T. Innerarity, E. Ralston, R. Blumenthal, Biochim. Biophys. Acta 1981, 647, 270.
66. For a review, see:, B. Sakman, E. Neher, Single-Channel Recording; Plenum Press: New York, 1995.